Výsledky vyhledávání

Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study

Autor: Masia M, Fernandez-Gonzalez M, Telenti G, Agullo V, Garcia J, Padilla S, Garcia-Abellan J, Galiana A, Gonzalo-Jimenez N, Gutierrez F

Publikováno v: JOURNAL OF AUTOIMMUNITY
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Objectives: Durability of the humoral immune response to SARS-CoV-2 has yet to be defined. We longitudinally evaluated during a 12-month period the antibody responses to SARS-CoV-2, and analysed predictors of antibody titres decline and seroreversion

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::959c22fa92f165e1468bd9b6cd26cccd
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11728

Zobrazit plný text záznamu

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19

Autor: Masia M, Padilla S, Garcia J, Garcia-Abellan J, Navarro A, Guillen L, Telenti G, Mascarell P, Botella A, Gutierrez F

Publikováno v: Frontiers in Medicine
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Background: Baricitinib is a Janus kinase (JAK) inhibitor with a broader anti-inflammatory activity than tocilizumab and an antiviral potential although no head-to-head trials are available. The benefits of adding baricitinib to patients with COVID-1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::70e84b3febb28762eb6161eefbb590fd
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12175

Zobrazit plný text záznamu

SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response

Autor: Masia M, Telenti G, Fernandez M, Garcia J, Agullo V, Padilla S, Garcia-Abellan J, Guillen L, Mascarell P, Asenjo J, Gutierrez F

Publikováno v: Open forum infectious diseases
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Background. The interdependencies of viral replication and the host immune response in patients with coronavirus disease 2019 (COVID-19) remain to be defined. We investigated the viral determinants of antibody response, the predictors of nonseroconve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::cb46a00f16e3762162cc8bb6e4d297bd
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11738

Zobrazit plný text záznamu

Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19

Autor: Padilla S, Telenti G, Guillen L, Garcia J, Garcia-Abellan J, Ding C, Mora A, Garcia-Pachon E, Gutierrez F, Masia M, COVID19-Elx Grp

Publikováno v: International journal of antimicrobial agents
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

This longitudinal, prospective cohort study aimed to assess risk of QTc interval prolongation and its predicting factors in subjects treated with combinations containing hydroxychloroquine (HCQ) for COVID-19. Moderate-to-severe QTc prolongation durin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5e85f57cb3d0869088224166f6f71f44
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9060

Zobrazit plný text záznamu

Preemptive interleukin-6 blockade in patients with COVID-19

Autor: Guillén L, Padilla S, Fernández M, Agulló V, García JA, Telenti G, García-Abellán J, Botella Á, Gutiérrez F, Masiá M

Publikováno v: SCIENTIFIC REPORTS
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Excessive interleukin-6 signaling is a key factor contributing to the cytokine release syndrome implicated in clinical manifestations of COVID-19. Preliminary results suggest that tocilizumab, a humanized monoclonal anti-interleukin-6 receptor antibo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b2b0f36824bbcfd9ae2a97629e23e379
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8221

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání